EULAR guidelines on ANCA-associated vasculitis in the real life

نویسندگان

چکیده

Anti-neutrophil cytoplasmic antibodies-associated vasculitides (AAVs) are a heterogenous group of inflammatory diseases which primarily involve small vessels and include granulomatosis with polyangiitis (GPA), microscopic (MPA) eosinophilic (EGPA). They present heterogeneous clinical manifestations, while their diagnosis management still remain challenge for clinicians. Nowadays, the treatment is based on two different regimens: remission-induction remission-maintenance treatment. The therapeutic armamentarium has grown over years, aim to lessen adverse effects, improve quality life patients maintain disease under control. Biological treatments future: they act pathogenic pathways may offer in future personalized approach tailored actual manifestations. latest guidelines were published 2015 by European League Against Rheumatism (EULAR) represent vade mecum AAVs. In this review, we will focus principal strategies treat We discuss therapy remission- maintenance therapy; have also distinguished GPA MPA from that EGPA, because pictures.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The CARI guidelines. ANCA serology in the diagnosis and management of ANCA-associated renal vasculitis.

a. Serum anti-neutrophil cytoplasmic antibody (ANCA) measurement should not be used alone in the initial diagnosis of ANCA-associated vasculitis (AAV) but should be used in combination with the gold standard of tissue diagnosis. (Level 1 evidence) b. Measurement of ANCA by both ELISA and indirect immunofluorescence (IIF) in combination ensures optimal test sensitivity and specificity. (Level I ...

متن کامل

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.

In this article, the 2009 European League Against Rheumatism (EULAR) recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have been updated. The 2009 recommendations were on the management of primary small and medium vessel vasculitis. The 2015 update has been developed by an international task force representing EULAR, the European Renal ...

متن کامل

Updates in ANCA-associated vasculitis.

Antineutrophil cytoplasm antibody (ANCA)-associated vasculitides are small-vessel vasculitides that include granulomatosis with polyangiitis (formerly Wegener's granulomatosis), microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). Renal-limited ANCA-associated vasculitides can be considered the fourth entity. Despite their rarity and still unknow...

متن کامل

How to treat ANCA‑associated vasculitis: practical messages from 2016 EULAR/ERA‑EDTA recommendations.

The European League against Rheumatism (EULAR) with the European Renal Association - European Dialysis and Transplant Association recently published an update of 2009 EULAR recommendations with a focus on the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV). In this article, we discuss the following key messages for clinical practice derived from these reco...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Beyond rheumatology

سال: 2021

ISSN: ['2612-5110']

DOI: https://doi.org/10.4081/br.2020.50